The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: An investigation of their expression as prognostic markers

European Journal of Cancer Part A

Volumn 32, Issue 9, 1996, Pages 1504-1509

  Takanami, I ^a   Tanaka, F ^a   Hashizume, T ^b   Kikuchi, K ^b   Yamamoto, Y ^a   Yamamoto, T ^a   Kodaira, S ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kanagawa Hospital   (Japan)

Author keywords

Basic fibroblast growth factor (bFGF); Immunohistochemical staining; Prognostic marker; Proliferation; Pulmonary adenocarcinoma; Type I basic fibroblast growth factor receptor (FGFR 1)

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030217819     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00620-6     Document Type: Article

References (24)

1. 1. Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog Growth Res 1989, 1, 207-235.
2. 2. Burges WH, Maciag T. The heparin-binding (fibroblast) growth factor family of protein. Annu Rev Biochem 1989, 58, 575-606.
3. 3. Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993, 53, 5297-5299.
4. 4. Jaye M, Schlessinger J, Dionne C. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1992, 1135, 185-199.
5. 5. Morrison RS, Yamaguchi F, Bruner JM, et al. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 1994, 54, 2794-2799.
6. 6. Cliffton EE, Luomanen KJ. Relationship of pathology to diagnosis and treatment. In Watson WL, ed. Lung Cancer: A Study of 5,000 Memorial Hospital Cases. C.V. Mosby Co., 1968, 376.
7. 7. Lung Cancer Task Force Japan Joint Committee on TNM Classification. Registration report of lung cancer in Japan (III), classification of staging and lung cancer according to TNM case summary from 1967-1969, National Cancer Center, 1975.
8. 8. Academic Investigation by the Japanese Association for Thoracic Surgery. Registration report of Japanese thoracic surgery in 1993. J Jpn Assoc Thorac Surg 1995, 43, 119-146.
9. 9. Vincent RG, Pickren JW, Lane WW, et al. The changing histopathology of lung cancer. Cancer 1977, 39, 1647-1655.
10. 10. Valaitis J, Warren S, Gamble D. Increasing incidence of adenocarcinoma of the lung. Cancer 1981, 47, 1042-1047.
11. 11. Matsuzaki K, Yoshitaka Y, Matsuo Y, Sasaki H, Nishikawa K. Monoclonal antibodies against heparin-binding growth factor II/-basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 1989, 86, 9911-9915.
12. 12. Venkateswaren S, Blanckaert V, Schelling M. Production of anti-fibroblast growth factor receptor monoclonal antibodies by in vitro immunization. Hybridoma 1992, 11, 729-739.
13. 13. Han IS, Sylvester SR, Kim KH, et al. Basic fibroblast growth factor is a testicular germ cell product which may regulate sertoli cell function. Mol Endocrinol 1993, 17, 889-897.
14. 14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29, 577-580.
15. 15. Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor: structural and biological properties. J Cell Physiol 1987, 5, 15-26.
16. 16. Eguchi J, Nomata K, Kanda S, et al. Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem Biophys Res Commun 1992, 183, 937-944.
17. 17. Tessler S, Neufeld G. Basic fibroblast growth factor accumulates in the nuclei of various bFGF producing cell type. J Cell Phys 1990, 145, 310-311.
18. 18. Suzui H, Takahashi JA, Fukumoto M, et al. Immunohistochemical study for basic fibroblast growth factor and fibroblast growth factor receptor I in pituitary adenomas. Neurosci Lett 1994, 171, 192-196.
19. 19. Adnane J, Gaudray P, Dionne CA, et al. BEK and FLG, two receptors to members of the FGF family, are amplified in subjects of human breast cancers. Oncogene 1991, 6, 659-663.
20. 20. Yamaguchi F, Saya H, Bruner J, et al. Differential expression of two FGF receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 1994, 91, 484-488.
21. 21. New BA, Yomau LC. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J Cell Physiol 1992, 150, 320-326.
22. 22. Kobrin MS, Yamanaka Y, Friess H, et al. Aberrant expression type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993, 53, 4741-4744.
23. 23. Tateishi M, Ishida T, Mitsudomi T, et al. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res 1990, 50, 7077-7080.
24. 24. Tateishi M, Ishida T, Mitsudomi T, et al. Prognostic implication of transforming growth factor α in adenocarcinoma of the lung - an immunohistochemical study. Br J Cancer 1991, 63, 130-133.